Table 1.

Description of the clinical and pathologic characteristics of the patient cohort

Included in NFM modelPatients
Tumor recurrence
P
n (%)Yes (%)No (%)
GenderYesFemale117 (19)27 (23)90 (77)
Male492 (81)145 (30)347 (71)0.209
Pathologic stageYespTa or pT1124 (20)20 (16)104 (84)
pT2202 (33)35 (17)167 (83)
pT3221 (36)86 (39)135 (61)
pT462 (10)31 (50)31 (50)0.000
Pathologic gradeYesGrade 291 (15)25 (28)66 (73)
Grade 3518 (85)147 (28)371 (72)0.485
Lymph node statusNopN0609 (100)172 (28)437 (72)
pN1-30 (0)0 (0)0 (0)NA
Carcinoma in situYesAbsent342 (56)103 (30)239 (70)
Present267 (44)69 (26)198 (74)0.142
Margin statusNoClear608 (100)172 (28)436 (72)
Involved1 (0)0 (0)1 (0)0.718
LVIYesAbsent431 (71)85 (20)346 (80)
Present178 (29)87 (49)91 (51)0.000
ChemotherapyNoNo609 (100)172 (28)437 (72)
Yes0 (0)0 (0)0 (0)NA
Total609 (100)172 (28)437 (72)
  • Abbreviations: LVI, lymphovascular invasion; NA, not applicable.